Biogen to Report First Quarter 2017 Financial Results on April 25, 2017
March 27 2017 - 4:01PM
Business Wire
Biogen Inc. (NASDAQ:BIIB) today announced it will report first
quarter 2017 financial results on Tuesday, April 25, 2017, before
the financial markets open.
Following the release of the financials, the Company will host a
live webcast where Biogen management will discuss the financial
results, at 8:30 am ET. To access the live webcast, please go to
the investor relations section of Biogen’s website at
www.biogen.com/investors. Following the live webcast, an archived
version of the call will be available at the same URL.
About Biogen
Through cutting-edge science and medicine, Biogen discovers,
develops and delivers worldwide innovative therapies for people
living with serious neurological and neurodegenerative diseases.
Founded in 1978, Biogen is a pioneer in biotechnology and today the
Company has the leading portfolio of medicines to treat multiple
sclerosis, has introduced the first and only approved treatment for
spinal muscular atrophy, and is at the forefront of neurology
research for conditions including Alzheimer’s disease, Parkinson’s
disease and amyotrophic lateral sclerosis (ALS). Building on its
heritage in biologics, Biogen also manufactures and commercializes
high-quality biosimilars. For more information, please visit
www.biogen.com. Follow us on social media – Twitter, LinkedIn,
Facebook, YouTube.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170327005929/en/
BiogenKaren Jewell, 781-464-2442Investor Relations
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Apr 2023 to Apr 2024